Hengrui Renews Global Phase III Push As China Players Plan Pivotal Multinational Trials

 
• By Dexter Jie Yan
  
Hengrui is making a comeback to the stage of global Phase III clinical studies. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from R&D